A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search

Is Niaspan(r) covered by any Medicare prescription drug plans?

Category: Coverage of Specific Drugs
Updated: Nov, 16 2023


Niaspan® is no longer covered by any Medicare Part D prescription drug plans.

To see the which Medicare prescription drug plans in your area that are now covering Niaspan, the Niaspan® generic equivalent, you can use our Drug Finder (Q1Rx.com)

For example, as compared to the 19 Florida Medicare Part D plans that covered Niaspan in 2014, no Florida, stand-alone Medicare Part D prescription drug plans provided coverage for "NIASPAN 1,000MG TABLET (NDC: 00074308090)". However, the generic Niacin is covered by 19 out of 21 Florida stand-alone Prescription drug plans and most Medicare Advantage plans that include prescription drug coverage.  Here is the link to the 2024 NIACIN 1,000MG results: Q1Rx.com/2024/fl/47335061381.  Most, PDPs and MAPDs cover the generic Niacin Q1Rx.com/2024/fl/47335061381.

More can be found on the changes of Niacin or Niaspan® Medicare Part D prescription drug plan coverage at the following:  q1medicare.com/PartD-Prescription-NiacinPartDExcluded.php


Historical Note about Niaspan coverage:

Niaspan was not included in the Humana Formulary as of December of 2005.

Back at this time, Niaspan was classified as a vitamin and not a drug, therefore not available under Medicare Part D and CMS Noted:

"There has been significant confusion among Part D plans and Medicare beneficiaries whether Niaspan® is included or excluded from the Medicare Prescription Drug Benefit. Several unique factors, including the mention of Niacin (nicotinic acid) as a USP “Formulary Key Drug Type” for 2006, likely contributed to this confusion.

 The Centers for Medicare & Medicaid Services (CMS) has not issued formal guidance clarifying the status of Niaspan, although many plans either inquired about the status of these products or concluded that since these are not Part D drugs, they should not be on their basic formularies.

CMS has determined that prescription Niacin products (e.g. Niaspan®, Niacor®) are prescription vitamins and, therefore, excluded from the definition of a Part D drug in accordance with statutory requirements. The effective date of this decision is June 1, 2006 due to the ambiguity and unique circumstances surrounding prescription Niacin products, and the previously authorized delay in issuance of EOB notices [see, FN1].

Prior to this effective date, Part D plans may treat prescription Niacin products as either excluded prescription vitamins or as Part D drugs.

After May 31, 2006, prescription Niacin products will be universally excluded from the definition of a Part D drug. Part D plans that currently have prescription Niacin products on their formularies should remove the drug using the standard negative change template request. This request should be submitted to PartDformularies@cms.hhs.gov at least 60 days prior to removal of the drug. All of these change requests must be submitted to CMS no later than April 1, 2006. Removal of the drug from the HPMS formulary files and the Medicare Prescription Drug Plan Finder formulary files should follow the standard process after submission of the negative change request.

[FN 1] On January 27, 2006, CMS notified Part D plans that they could wait until March to send the first Explanation of Benefits (EOB) document to members. A plan choosing to send the first EOB to members during the month of March must ensure that the EOB reflects any activity for the months of January and February. In addition, plans must send an EOB extension notice during the month of February for all members who utilized the prescription drug benefit during the month of January.

In the interest of full disclosure, plans that currently identify prescription Niacin products on their formularies should take steps to alert potential enrollees of this impending change, and must notify affected enrollees in one of the following ways:

• By providing direct written notice to affected enrollees at least 60 days prior to the effective date of the change; or

• By providing the enrollee with a 60-day supply of the Part D drug at the time an affected enrollee requests a refill of the Part D drug under the same terms as previously allowed and provide written notice of the formulary change.

[Note: This method will not be available for prescription Niacin products under any circumstances after May 31, 2006]

[Medicare] Part D plans must provide written notice of these changes to affected enrollees through a member formulary medication change notice and/or the Explanation of Benefits (EOB). These documents are considered marketing materials and must comply with CMS marketing guideline requirements. In addition, notice of the formulary change must be posted on the Part D plan's Web site, in accordance with the marketing guideline requirements. The actual written notice document does not need to be posted."






Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


Browse FAQ Categories


Compare Prices Using a Drug Discount Card
Prescription Discounts are
easy as 1-2-3
  1. Locate lowest price drug and pharmacy
  2. Show card at pharmacy
  3. Get instant savings!
Your drug discount card is available to you at no cost.




Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.